<?xml version='1.0' encoding='UTF-8'?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/" xmlns:blogger="http://schemas.google.com/blogger/2008" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-5341943643025549558</atom:id><lastBuildDate>Fri, 09 May 2014 12:32:18 +0000</lastBuildDate><category>JDD</category><category>derm matters</category><category>journal of drugs in dermatology</category><category>derm</category><category>jddonline</category><category>ODAC</category><category>dermmatters</category><category>dermatology</category><category>james gormley</category><category>best dermatology blogs</category><category>FDA</category><category>derm minute</category><category>james j. gormley</category><category>jamie trapp</category><category>botox</category><category>dermatology 2.0</category><category>dermatology residents</category><category>hema sundaram</category><category>hyaluronic acid fillers</category><category>leon kircik</category><category>luciana halliday</category><category>magdalene dohil</category><category>nanotechnology</category><category>orlando derm</category><category>s. manjula jegasothy</category><category>skin cancer foundation</category><category>treatment adherence</category><category>AACS</category><category>AAD</category><category>AAMC</category><category>AFIRM</category><category>AOA status</category><category>Albert Einstein College</category><category>Alopecia</category><category>BRAF V600E</category><category>C02 lasers</category><category>CDC</category><category>DOD</category><category>DUSA</category><category>David Gurevich</category><category>Diode lasers</category><category>EAI</category><category>Galderma</category><category>Georgia Tech</category><category>HAL Medical Blog Awards</category><category>John Theurer Cancer Center</category><category>MRSA</category><category>Marcus Zervos</category><category>NSF</category><category>NYU</category><category>PDAs</category><category>PLLA</category><category>PV-10</category><category>USLME scores</category><category>Yervoy</category><category>Yongxing Hu</category><category>acne</category><category>adam friedman</category><category>adnan nasir</category><category>air force</category><category>alan shalita</category><category>alice gottlieb</category><category>allergan</category><category>american society of plastic surgeons</category><category>amy mcmichael</category><category>amy taub video</category><category>amy wilder</category><category>andrew alexis</category><category>andrew friedman</category><category>army</category><category>asps</category><category>at-home treatments</category><category>best medical blogs</category><category>best on the web</category><category>best plastic surgery blogs</category><category>botox cosmetic</category><category>camouflage cosmetics</category><category>caroline barrett</category><category>cbpa</category><category>cell-based assay</category><category>cellulite</category><category>chad hivnor</category><category>clinical photo</category><category>cosmeceutical</category><category>cost effectiveness of botulinum toxins</category><category>deborah sarnoff</category><category>depression</category><category>derm residencies</category><category>diane thiboutot</category><category>dr. cheryl burgess</category><category>dr. kenneth beer</category><category>dysport</category><category>eliot battle</category><category>engines of creation</category><category>erin gilbert</category><category>erytheme ab igne</category><category>ethnic skin</category><category>eyejuvenation</category><category>eyelashes</category><category>francois fournier</category><category>futurederm</category><category>geisinger</category><category>genentech</category><category>heather lloyd</category><category>heidi waldorf</category><category>hillary baldwin</category><category>howard pride md</category><category>hyaluronidase</category><category>iPads</category><category>iPods</category><category>irene vergilis</category><category>irene vergilis-kalner</category><category>james krueger</category><category>jeffrey frentzen</category><category>joel schlessinger</category><category>joseph rosen md</category><category>joshua zeichner</category><category>julian trevino</category><category>juvederm</category><category>juvederm xc</category><category>k. eric drexler</category><category>kathy lopes</category><category>laboratory for investigative dermatology</category><category>laptop exposure</category><category>larry deklinski</category><category>laser treatments</category><category>latisse</category><category>ld50</category><category>leslie baumann video</category><category>lidocaine</category><category>lipstick effect</category><category>marie briden</category><category>mark kaufmann</category><category>martin braun</category><category>mascara</category><category>mealamoma</category><category>medical photography</category><category>medication compliance</category><category>medicine 2.0</category><category>melanoma awareness month</category><category>michael crichton</category><category>michelle lowes</category><category>military medicine</category><category>nicki zevola</category><category>npf</category><category>orlando dermatology</category><category>orlandoderm</category><category>pat altavilla</category><category>patient education</category><category>pediatrics</category><category>perry robins</category><category>ph itin</category><category>practice management</category><category>prey</category><category>provectus</category><category>psoriasis</category><category>restylane</category><category>robert f. doman</category><category>robert gotkin</category><category>roche group</category><category>rockefeller university</category><category>sermo</category><category>sermo selected site award</category><category>shamokin</category><category>shelley tanner</category><category>skin infections</category><category>skin of color</category><category>skin of color center</category><category>skin of color seminar series</category><category>ssri</category><category>st. luke&#39;s-roosevelt</category><category>susan taylor</category><category>susan weinkle md</category><category>the news item</category><category>the sterile eye</category><category>timothy g. terrell</category><category>unwanted hair</category><category>walk to cure psoriasis</category><category>web 2.0</category><category>webicina</category><category>zelboraf</category><category>Øystein Horgmo</category><title>DermMatters</title><description></description><link>http://www.dermmatters.com/</link><managingEditor>noreply@blogger.com (Editor)</managingEditor><generator>Blogger</generator><openSearch:totalResults>53</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-5089801886222908763</guid><pubDate>Wed, 23 Apr 2014 23:38:00 +0000</pubDate><atom:updated>2014-04-23T19:38:45.225-04:00</atom:updated><title>Photodynamic Therapy to Treat Diseases</title><atom:summary type="text">













&lt;!--
 /* Font Definitions */
@font-face
 {font-family:&quot;ＭＳ 明朝&quot;;
 mso-font-charset:78;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536870145 1791491579 18 0 131231 0;}
@font-face
 {font-family:&quot;Cambria Math&quot;;
 panose-1:2 4 5 3 5 4 6 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536870145 </atom:summary><link>http://www.dermmatters.com/2014/04/photodynamic-therapy-to-treat-diseases.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-1210830489717515088</guid><pubDate>Wed, 23 Apr 2014 23:20:00 +0000</pubDate><atom:updated>2014-04-23T19:20:03.549-04:00</atom:updated><title>Triclosan and Antibacterial Soaps</title><atom:summary type="text">













&lt;!--
 /* Font Definitions */
@font-face
 {font-family:&quot;Cambria Math&quot;;
 panose-1:2 4 5 3 5 4 6 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536870145 1107305727 0 0 415 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
 {mso-style-unhide:no;
 mso-style-qformat:yes;
 mso-style-parent:&quot;&quot;;
 margin:0in;
 </atom:summary><link>http://www.dermmatters.com/2014/04/triclosan-and-antibacterial-soaps.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-5377567920423086423</guid><pubDate>Tue, 04 Feb 2014 20:40:00 +0000</pubDate><atom:updated>2014-02-04T15:40:32.332-05:00</atom:updated><title>WHO&#39;s Who in Tropical Diseases?</title><atom:summary type="text">













&lt;!--
 /* Font Definitions */
@font-face
 {font-family:&quot;Cambria Math&quot;;
 panose-1:2 4 5 3 5 4 6 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536870145 1107305727 0 0 415 0;}
@font-face
 {font-family:Calibri;
 panose-1:2 15 5 2 2 2 4 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 </atom:summary><link>http://www.dermmatters.com/2014/02/whos-who-in-tropical-diseases.html</link><author>noreply@blogger.com (Editor)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/-FzCs8hWTVLM/UvFQBRCVaGI/AAAAAAAAARg/cipbPjQinsI/s72-c/palm-tree-silhouette.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-9035950091621401612</guid><pubDate>Tue, 01 Oct 2013 15:08:00 +0000</pubDate><atom:updated>2013-10-01T11:11:03.671-04:00</atom:updated><title>The Quest for Viable Alopecia Treatments for Men and Women</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:</atom:summary><link>http://www.dermmatters.com/2013/10/the-quest-for-viable-alopecia.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-3833542134022404130</guid><pubDate>Thu, 12 Sep 2013 18:21:00 +0000</pubDate><atom:updated>2013-09-12T13:44:59.876-04:00</atom:updated><title>Avoiding Skin Cancer for Teens - Appeal to Vanity</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
 {font-family:&quot;Cambria Math&quot;;
 panose-1:2 4 5 3 5 4 6 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:</atom:summary><link>http://www.dermmatters.com/2013/08/avoiding-skin-cancer-for-teens-appeal.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-2824328813597843379</guid><pubDate>Wed, 17 Jul 2013 13:58:00 +0000</pubDate><atom:updated>2013-07-17T10:00:38.902-04:00</atom:updated><title>Therapeutic Options for Chronic Idiopathic Urticaria</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
 {font-family:OpenSymbol;
 mso-font-alt:&quot;Arial Unicode MS&quot;;
 mso-font-charset:128;
 mso-generic-font-family:auto;
 mso-font-pitch:auto;
 mso-font-signature:0 0 </atom:summary><link>http://www.dermmatters.com/2013/07/therapeutic-options-for-chronic.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-6283744769689202462</guid><pubDate>Tue, 04 Jun 2013 16:58:00 +0000</pubDate><atom:updated>2013-06-04T14:59:15.365-04:00</atom:updated><title>New Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne</title><atom:summary type="text">
Acne is one of the most common skin conditions in children and adolescents, and there are increasing amounts of acne seen in younger age groups. In addition, acne and acne-like conditions occur at different ages in childhood, including neonates, infants, and young children, sometimes associated with significant disease processes.

Although acne is so common, and there has been a great expansion </atom:summary><link>http://www.dermmatters.com/2013/06/new-evidence-based-recommendations-for.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-2193396183688074265</guid><pubDate>Mon, 13 May 2013 13:24:00 +0000</pubDate><atom:updated>2013-05-13T09:50:55.604-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Alopecia</category><title>Hair Loss in the Clinic: Update on Alopecia Areata</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:</atom:summary><link>http://www.dermmatters.com/2013/05/hair-loss-in-clinic-update-on-alopecia.html</link><author>noreply@blogger.com (Editor)</author><thr:total>1</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-6667658404800955387</guid><pubDate>Thu, 18 Apr 2013 21:01:00 +0000</pubDate><atom:updated>2013-04-18T17:01:35.865-04:00</atom:updated><title>Does Transecting a Melanoma on Initial Biopsy Affect the Outcome?</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
 {font-family:&quot;Cambria Math&quot;;
 panose-1:2 4 5 3 5 4 6 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:</atom:summary><link>http://www.dermmatters.com/2013/04/does-transecting-melanoma-on-initial_8275.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-5451051288563877100</guid><pubDate>Tue, 05 Mar 2013 12:52:00 +0000</pubDate><atom:updated>2013-03-05T07:52:32.828-05:00</atom:updated><title>Evidence for Supplement Use in Atopic Dermatitis</title><atom:summary type="text">













&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:3 0 0 0 1 0;}
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:3 0 0 0 1 0;}
 /* </atom:summary><link>http://www.dermmatters.com/2013/03/evidence-for-supplement-use-in-atopic.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-105998311391671016</guid><pubDate>Thu, 31 Jan 2013 19:14:00 +0000</pubDate><atom:updated>2013-01-31T14:36:00.015-05:00</atom:updated><title>Will Sunscreen Use Affect Vitamin D?</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
 {font-family:&quot;Cambria Math&quot;;
 panose-1:2 4 5 3 5 4 6 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:3</atom:summary><link>http://www.dermmatters.com/2013/01/will-sunscreen-use-affect-vitamin-d.html</link><author>noreply@blogger.com (Editor)</author><thr:total>1</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-6888132338147181706</guid><pubDate>Tue, 08 Jan 2013 18:26:00 +0000</pubDate><atom:updated>2013-02-07T20:40:57.623-05:00</atom:updated><title>Recent Clinical Trials in Dermatology</title><atom:summary type="text">

A Phase 2 Bilateral (Split-face) Comparison Study to Assess 2 Formulations of ELAPR Compared to Juvéderm® Ultra Plus for the Treatment of Moderate to Severe Nasolabial Folds

Sponsored by Elastagen Pty Ltd, the purpose of this study is to recruit patients presenting to the clinic for treatment of moderate to severe nasolabial folds to receive either ELAPR002b or ELAPR002d for the treatment of </atom:summary><link>http://www.dermmatters.com/2013/01/recent-clinical-trials-in-dermatology.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-5499367458776812412</guid><pubDate>Tue, 02 Oct 2012 18:28:00 +0000</pubDate><atom:updated>2013-02-07T20:53:50.542-05:00</atom:updated><title>2012: An Extraordinary Period of Growth and Achievement for Nanodermatology</title><atom:summary type="text">The past year and a half has marked an extraordinary period of growth and achievement in the field of nanodermatology, that is, nanotechnology as it relates to dermatology.  In brief, nanotechnology is defined as the study, investigation, manipulation, utilization, and translation of materials that have at least one dimension between the size range of 1-100 nm. At this remarkably small scale (1 </atom:summary><link>http://www.dermmatters.com/2012/10/2012-extraordinary-period-of-growth-and.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-5205814458571571276</guid><pubDate>Wed, 27 Jun 2012 12:49:00 +0000</pubDate><atom:updated>2013-02-07T20:55:25.519-05:00</atom:updated><title>Laser Treatments for Psoriasis?</title><atom:summary type="text">

Dr. Kendra Bergstrom of the Department of Dermatology at Indiana State University reviews the latest in treatments for psoriasis and acne...

Laser Treatments for Psoriasis

UVB Laser

Levia LiteBrush
The Levia system was approved by the FDA in January 2010 and is marketed as “Personal Targeted Phototherapy” for at-home use.  It is indicated for treatment of dermatoses responding to </atom:summary><link>http://www.dermmatters.com/2012/06/laser-treatments-for-psoriasis.html</link><author>noreply@blogger.com (Editor)</author><thr:total>1</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-3986726635529909983</guid><pubDate>Mon, 11 Jun 2012 14:51:00 +0000</pubDate><atom:updated>2013-02-07T20:56:33.983-05:00</atom:updated><title>New Anti-aging Laser Technology</title><atom:summary type="text">

Laser technologies that allow for private treatment at home, once only available in a doctor&#39;s office, are under development for the consumer market.  While many of thee home devices offer energy outputs and in-machine safety features similar to office installations, there are some limitations.  Discomfort and frequent longer treatment times may occur, but in the hands of a well-informed </atom:summary><link>http://www.dermmatters.com/2012/06/no-place-like-home-for-new-anti-aging.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-1752674910735371927</guid><pubDate>Fri, 27 Apr 2012 15:15:00 +0000</pubDate><atom:updated>2012-05-02T14:30:38.847-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">at-home treatments</category><category domain="http://www.blogger.com/atom/ns#">Diode lasers</category><category domain="http://www.blogger.com/atom/ns#">laser treatments</category><category domain="http://www.blogger.com/atom/ns#">unwanted hair</category><title>No Place Like Home for New Laser Technologies</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
 {font-family:&quot;ＭＳ 明朝&quot;;
 mso-font-charset:78;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:-536870145 1791491579 18 0 131231 0;}
</atom:summary><link>http://www.dermmatters.com/2012/04/at-home-laser-treatments.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-5861795723493043855</guid><pubDate>Tue, 27 Mar 2012 20:01:00 +0000</pubDate><atom:updated>2013-02-07T20:57:30.335-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">AAD</category><category domain="http://www.blogger.com/atom/ns#">JDD</category><title>Memories of the 70th Annual American Academy of Dermatology (AAD) Conference</title><atom:summary type="text">

&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Arial;
 panose-1:2 11 6 4 2 2 2 2 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:3 0 0 0 1 0;}
@font-face
 {font-family:&quot;ＭＳ 明朝&quot;;
 mso-font-charset:78;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:1 0 16778247 0 131072 0;}
@font-face
 {font-family:Cambria;</atom:summary><link>http://www.dermmatters.com/2012/03/memories-of-70th-annual-american.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-481485639405139262</guid><pubDate>Tue, 31 Jan 2012 21:11:00 +0000</pubDate><atom:updated>2012-01-31T16:11:02.167-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">cellulite</category><title>Cellulite Q&amp;A with Dr. Ranella Hirsch</title><atom:summary type="text">
A very high percentage of the female population reports being affected by cellulite. Although exercise and a balanced diet are clinically proven to help maintain a healthy weight, these can only do so much to prevent this stubborn issue which affects women of all shapes and sizes. Here, Dr. Ranella Hirsch, board-certified dermatologist, explains the facts and figures about cellulite. 
 
Q: What </atom:summary><link>http://www.dermmatters.com/2012/01/cellulite-q-with-dr-ranella-hirsch.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-1339963394044074886</guid><pubDate>Wed, 25 Jan 2012 21:46:00 +0000</pubDate><atom:updated>2012-01-25T16:46:31.694-05:00</atom:updated><title>ODAC 2012—Another Great Conference</title><atom:summary type="text">












&lt;!--
 /* Font Definitions */
@font-face
 {font-family:Cambria;
 panose-1:2 4 5 3 5 4 6 3 2 4;
 mso-font-charset:0;
 mso-generic-font-family:auto;
 mso-font-pitch:variable;
 mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
 {mso-style-parent:&quot;&quot;;
 margin:0in;
 margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:12.0pt;
 </atom:summary><link>http://www.dermmatters.com/2012/01/odac-2012another-great-conference.html</link><author>noreply@blogger.com (Editor)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/-Hz8Giwt5nII/TyB4K8s5qkI/AAAAAAAAANw/nR_zllzACbA/s72-c/9thAnnualODACLogo-copy.png" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-4932638280780087325</guid><pubDate>Thu, 22 Dec 2011 21:00:00 +0000</pubDate><atom:updated>2011-12-22T16:00:49.753-05:00</atom:updated><title>Genetic Mosaicism, Skin Color, and Cosmetic Dermatology</title><atom:summary type="text">












&lt;!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
 {mso-style-parent:&quot;&quot;;
 margin:0in;
 margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:12.0pt;
 font-family:&quot;Times New Roman&quot;;
 mso-fareast-font-family:&quot;Times New Roman&quot;;
 mso-bidi-font-family:&quot;Times New Roman&quot;;}
@page Section1
 {size:8.5in 11.0in;
 margin:1.0in 1.0in 1.0in 1.0in;
 mso-header-margin:</atom:summary><link>http://www.dermmatters.com/2011/12/genetic-mosaicism-skin-color-and.html</link><author>noreply@blogger.com (Editor)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/-NomyJ2xvz8g/TvOZsYop3DI/AAAAAAAAANo/Ou1-v5_DOSQ/s72-c/ZoeColor.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-4606539144409157796</guid><pubDate>Thu, 18 Aug 2011 00:09:00 +0000</pubDate><atom:updated>2011-08-18T14:23:25.644-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">BRAF V600E</category><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">genentech</category><category domain="http://www.blogger.com/atom/ns#">JDD</category><category domain="http://www.blogger.com/atom/ns#">mealamoma</category><category domain="http://www.blogger.com/atom/ns#">roche group</category><category domain="http://www.blogger.com/atom/ns#">zelboraf</category><title>FDA Approves Zelboraf and Companion Diagnostic Test for Late-stage Skin Cancer</title><atom:summary type="text">The U.S. Food and Drug Administration (FDA) today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage or unresectable melanoma.
Zelboraf is specifically indicated for the treatment of patients with melanoma whose tumors express a gene mutation called BRAF V600E. The drug has not been studied in patients whose melanoma tests negative for that mutation by an FDA approved </atom:summary><link>http://www.dermmatters.com/2011/08/fda-approves-zelboraf-and-companion.html</link><author>noreply@blogger.com (Editor)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/-azzAyDdqWpE/Tk1AnfmIGjI/AAAAAAAAANE/s2F_IIIXDL0/s72-c/logo1c.png" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-2783993974560554465</guid><pubDate>Tue, 02 Aug 2011 02:46:00 +0000</pubDate><atom:updated>2011-08-01T22:59:51.522-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">allergan</category><category domain="http://www.blogger.com/atom/ns#">botox</category><category domain="http://www.blogger.com/atom/ns#">cbpa</category><category domain="http://www.blogger.com/atom/ns#">cell-based assay</category><category domain="http://www.blogger.com/atom/ns#">derm matters</category><category domain="http://www.blogger.com/atom/ns#">derm minute</category><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">JDD</category><category domain="http://www.blogger.com/atom/ns#">journal of drugs in dermatology</category><category domain="http://www.blogger.com/atom/ns#">ld50</category><category domain="http://www.blogger.com/atom/ns#">timothy g. terrell</category><title>DermMinute With Dr. Timothy Terrell</title><atom:summary type="text">By James J. Gormley
Timothy G. Terrell, DVM, PhD, DACVP, earned his Doctorate of Veterinary Medicine (DVM) at Texas A&amp;M University and received a Ph.D. in Comparative Pathology from the University of California at Davis. He is a board-certified veterinary pathologist with more than 32 years of experience in the pharmaceutical and biotechnology industry. He is currently the Senior Vice President </atom:summary><link>http://www.dermmatters.com/2011/08/dermminute-with-dr-timothy-terrell.html</link><author>noreply@blogger.com (Editor)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/-WcrXsyHIBKs/TjdjR3XL2kI/AAAAAAAAANA/xTx4wBXyZQQ/s72-c/Terrell_Tim.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-7043024216294262369</guid><pubDate>Thu, 19 May 2011 21:14:00 +0000</pubDate><atom:updated>2011-05-23T11:31:20.760-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">John Theurer Cancer Center</category><category domain="http://www.blogger.com/atom/ns#">melanoma awareness month</category><category domain="http://www.blogger.com/atom/ns#">NYU</category><category domain="http://www.blogger.com/atom/ns#">perry robins</category><category domain="http://www.blogger.com/atom/ns#">provectus</category><category domain="http://www.blogger.com/atom/ns#">PV-10</category><category domain="http://www.blogger.com/atom/ns#">skin cancer foundation</category><category domain="http://www.blogger.com/atom/ns#">Yervoy</category><title>Melanoma Awareness Month Celebrates Important New Treatments</title><atom:summary type="text">  
&lt;!--
 /* Font Definitions */
@font-face
	{font-family:Arial;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;</atom:summary><link>http://www.dermmatters.com/2011/05/melanoma-awareness-month-celebrates.html</link><author>noreply@blogger.com (Editor)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-8156348932479884586</guid><pubDate>Wed, 11 May 2011 15:18:00 +0000</pubDate><atom:updated>2011-05-11T11:19:05.509-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">derm matters</category><category domain="http://www.blogger.com/atom/ns#">JDD</category><category domain="http://www.blogger.com/atom/ns#">jddonline</category><category domain="http://www.blogger.com/atom/ns#">sermo</category><category domain="http://www.blogger.com/atom/ns#">sermo selected site award</category><title>DermMatters Wins 4th Award!</title><atom:summary type="text">By James J. Gormley 
DermMatters has received its fourth award, the “Sermo Selected Site” distinguished honor. 

The list of sites that are receiving this recognition will be announced to Sermo&#39;s 120,000 physician members and also featured on the new Sermo Selected microsite.</atom:summary><link>http://www.dermmatters.com/2011/05/dermmatters-wins-4th-award.html</link><author>noreply@blogger.com (Editor)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/-CTv89iaD_Mk/TcqoKuNhPjI/AAAAAAAAAM8/JFkLerdMu6M/s72-c/Selected_Selected_Site_wide.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-5341943643025549558.post-6963663484893091158</guid><pubDate>Thu, 07 Apr 2011 19:32:00 +0000</pubDate><atom:updated>2011-04-07T16:35:19.857-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">acne</category><category domain="http://www.blogger.com/atom/ns#">derm matters</category><category domain="http://www.blogger.com/atom/ns#">JDD</category><category domain="http://www.blogger.com/atom/ns#">joshua zeichner</category><category domain="http://www.blogger.com/atom/ns#">journal of drugs in dermatology</category><category domain="http://www.blogger.com/atom/ns#">patient education</category><category domain="http://www.blogger.com/atom/ns#">treatment adherence</category><title>The Importance of Patient Education When Treating Acne</title><atom:summary type="text">  
&lt;!--
 /* Font Definitions */
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:&quot;&quot;;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;</atom:summary><link>http://www.dermmatters.com/2011/04/importance-of-patient-education-when.html</link><author>noreply@blogger.com (Editor)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/-vW2slazaKg4/TZ4PIyZJSyI/AAAAAAAAAM4/Xis_isA6A-g/s72-c/JoshuaZeichnerMD2-162x266.jpg" height="72" width="72"/><thr:total>0</thr:total></item></channel></rss>